Market Currents
The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%)...
-
Tuesday, June 26, 2012, 11:17 AM ETThe Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%) shareholders over whether the company made "potentially materially false and misleading" statements about its prospects and operations. The announcement cites the long run-up in Celgene's shares before they plunged following a regulatory setback for its Revlimid drug.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
